Topic: Eric Winer
Even microscopic spread of breast cancer raises risk that the disease will recur, study findsBreast cancer patients with even the tiniest spread of the disease to a lymph node have a much higher risk of it recurring years later and may need ...
The quest to design cancer drugs using the latest advances in molecular biology sometimes reminds me of Galileo Galilei and his newfangled telescope. Avastin, an anticancer pharmaceutical Genentech that uses a wholly different mechanism than the highly toxic chemotherapies that try to ...
Amgen's experimental denosumab is more effective than Novartis' blockbuster Zometa in preventing advanced breast cancer from damaging bone, Amgen said in a press release Tuesday.. The news caused Amgen ( AMGN - news - people ) shares to surge 13% to $59.30 in after-hours ...
The past year saw many advances in cancer research in areas including hard-to-treat cancers, new drug approvals, personalized medicine and reducing recurrence, according to a report published online Dec. 22 in the Journal of Clinical Oncology.. The authors, a group of 21 ...
Bone drug Zometa may help fight breast cancer when given with chemo, study suggestsNew research adds fresh hope that a drug that strengthens bones might also fight breast cancer. Women who were given the drug, Zometa, as part of their initial treatment ...
9/4/2008 Print E-mail While tremendous progress in screening and treatment for breast cancer has been made in recent years, some 184,000 new cases of breast cancer will be diagnosed in the United States in 2008, and about 41,000 ...
Rather than buzzing about some promising new drug or treatment, lots of docs are talking about when patients shouldn't get treated with particular drugs.. "We're starting to better understand and explore less treatment instead of more for colorectal cancer patients ...
Rather than buzzing about some promising new drug or treatment, lots of docs are talking about when patients shouldn't get treated with particular drugs.. "We're starting to better understand and explore less treatment instead of more for colorectal cancer patients ...
10/10/2007 Print E-mail When added to a standard chemotherapy, the drug paclitaxel (Taxol) cuts the recurrence of breast cancer by 41 percent in women with a particular form of tumor, a new study finds.. "Over the last 10 years, we ...
9/25/2007 Print E-mail Breast cancer death rates continue to decline more than 2 percent annually, a long-running trend that can be traced to early detection and better treatments, according to a new American Cancer Society report.. One is the decreased ...
Video Gallery
-
Eric P. Winer, MD: Medical Economics ...
Dr. Eric Winer moderated a panel at the 34th Annual ...2012-01-11 -
Eric P. Winer, MD: Endocrine Therapy ...
Dr. Eric Winer presented one of the plenary sessions at ...2012-01-11 -
2010 SABCS Interview with Eric P ...
Interview with Eric P. Winer, MD, director of the Breast ...2010-12-11
